Trial
NCT05114460
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Opioid Overdose
Intervention
Naloxone
Why stopped
The U.S. Department of Health and Human Services Office of Human Research Protections issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. Recruitment for this trial will not reopen.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-18